| Id |
Subject |
Object |
Predicate |
Lexical cue |
| p1_all0 |
28-91 |
Intervention |
denotes |
3-Hydroxyphthalic Anhydride- Modified Bovine Beta-Lactoglobulin |
| p2_i0 |
28-91 |
Pharmacological |
denotes |
3-Hydroxyphthalic Anhydride- Modified Bovine Beta-Lactoglobulin |
| p1_all1 |
194-273 |
Intervention |
denotes |
3-hydroxyphthalic anhydride (3HP)-modified bovine beta-lactoglobulin (3HP-β-LG) |
| p2_i1 |
194-273 |
Pharmacological |
denotes |
3-hydroxyphthalic anhydride (3HP)-modified bovine beta-lactoglobulin (3HP-β-LG) |
| p1_all2 |
428-459 |
Intervention |
denotes |
3HP-β-LG-containing vaginal gel |
| p2_i2 |
428-459 |
Pharmacological |
denotes |
3HP-β-LG-containing vaginal gel |
| p2_o2 |
488-501 |
Physical |
denotes |
HPV infection |
| p1_all3 |
488-523 |
Outcome |
denotes |
HPV infection and reduce viral load |
| p1_all4 |
628-636 |
Intervention |
denotes |
3HP-β-LG |
| p1_all5 |
700-708 |
Intervention |
denotes |
3HP-β-LG |
| p1_all6 |
1193-1233 |
Intervention |
denotes |
3HP-modified chicken ovalbumin (3HP-OVA) |
| p2_i3 |
1193-1233 |
Pharmacological |
denotes |
3HP-modified chicken ovalbumin (3HP-OVA) |
| p2_o6 |
1290-1307 |
Physical |
denotes |
anti-HPV activity |
| p1_all7 |
1508-1516 |
Intervention |
denotes |
3HP-β-LG |
| p2_o7 |
1535-1565 |
Physical |
denotes |
host cell or blood circulation |
